Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RITUXIMAB-ABBS for Nephrotic syndrome: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 61 adverse event reports in the FDA FAERS database where RITUXIMAB-ABBS was used for Nephrotic syndrome.

Most Reported Side Effects for RITUXIMAB-ABBS

Side Effect Reports % Deaths Hosp.
Off label use 2,167 49.9% 125 256
Intentional product use issue 273 6.3% 77 124
Dyspnoea 208 4.8% 65 104
Pain 205 4.7% 60 102
Rheumatoid arthritis 202 4.7% 64 109
Intentional dose omission 196 4.5% 14 76
Fatigue 195 4.5% 60 94
Drug ineffective 186 4.3% 59 73
Hypertension 183 4.2% 64 99
Infusion related reaction 183 4.2% 55 76
Rash 183 4.2% 51 102
Pyrexia 180 4.1% 50 119
Nausea 170 3.9% 36 74
Death 167 3.8% 167 19
Headache 167 3.8% 65 78

Other Indications for RITUXIMAB-ABBS

Rheumatoid arthritis (820) Product used for unknown indication (373) Diffuse large b-cell lymphoma (288) Immune thrombocytopenia (235) Vasculitis (151) B-cell lymphoma (133) Systemic lupus erythematosus (129) Mantle cell lymphoma (123) Multiple sclerosis (120) Non-hodgkin's lymphoma (111)

Other Drugs Used for Nephrotic syndrome

CORTICOTROPIN (1,254) RITUXIMAB (1,135) CYCLOSPORINE (721) MYCOPHENOLATE MOFETIL (623) PREDNISOLONE (538) TACROLIMUS (535) PREDNISONE (494) METHYLPREDNISOLONE (490) CYCLOPHOSPHAMIDE (220) OBINUTUZUMAB (125)

Related Pages

RITUXIMAB-ABBS Full Profile All Nephrotic syndrome Drugs RITUXIMAB-ABBS Demographics RITUXIMAB-ABBS Timeline